Ovarian cancer

Open Access
Serum Creatinine Elevation as a Risk Factor for Niraparib-induced Hematologic Toxicity
KOKI HASHIMOTO, KAZUYOSHI KAWAKAMI, TAKASHI YOKOKAWA, NAOKI SHIBATA, AZUSA SOEJIMA, TAKAHITO SUGISAKI, YUKA MORI, HISANORI SHIMIZU, MAYU YUNOKAWA, HIROYUKI KANAO and MASAKAZU YAMAGUCHI

Anticancer Research October 2023, 43 (10) 4533-4541; DOI: https://doi.org/10.21873/anticanres.16647
You have access
Interval Cytoreductive Surgery and Heated Intraperitoneal Chemotherapy for Ovarian Cancer: Report of a Single-center Experience
CHRYSOULA LIAKOU, ANASTASIOS PANDRAKLAKIS, MARIA-CLELIA LA RUSSA, HILARY TURNBULL, JOAQUIN NIETO, TIMOTHY DUNCAN, ADAM STEARNS and NIKOLAOS BURBOS

Anticancer Research October 2023, 43 (10) 4593-4599; DOI: https://doi.org/10.21873/anticanres.16653
Open Access
Immunological Markers of Chlamydia trachomatis Infection in Epithelial Ovarian Cancer
TIINA HOLSTER, ELINA URPILAINEN, JORMA PAAVONEN, ULLA PUISTOLA and MIRJA PUOLAKKAINEN

Anticancer Research September 2023, 43 (9) 4037-4043; DOI: https://doi.org/10.21873/anticanres.16592
Open Access
Real-world Efficacy and Safety of Bevacizumab for Advanced or Recurrent Müllerian Cancer: A Single-institutional Experience
TAKESHI FUKUDA, TAKUYA NODA, EIJIRO UCHIKURA, YUICHIRO AWAZU, REIKO TASAKA, KENJI IMAI, MAKOTO YAMAUCHI, TOMOYUKI ICHIMURA, TOMOYO YASUI and TOSHIYUKI SUMI

Anticancer Research July 2023, 43 (7) 3097-3105; DOI: https://doi.org/10.21873/anticanres.16481
You have access
Tissue Expression and Prognostic Role of CXCL12 and CXCR4 in High-grade Serous Ovarian Carcinoma
HYUNJI LIM, SE IK KIM, EUN NA KIM, MARIA LEE, CHEOL LEE, JAE-WEON KIM and HYUN HOON CHUNG

Anticancer Research July 2023, 43 (7) 3331-3340; DOI: https://doi.org/10.21873/anticanres.16509
Open Access
Somatic Variants in DNA Damage Response Genes in Ovarian Cancer Patients Using Whole-exome Sequencing
JOANNA LOPACINSKA-JOERGENSEN, DOUGLAS V.N.P. OLIVEIRA, TIM SVENSTRUP POULSEN, CLAUS K. HOEGDALL and ESTRID V. HOEGDALL

Anticancer Research May 2023, 43 (5) 1891-1900; DOI: https://doi.org/10.21873/anticanres.16348
Open Access
Efficacy and Safety of Platinum-based Chemotherapy With Bevacizumab Followed by Bevacizumab Maintenance for Recurrent Ovarian, Fallopian Tube, and Primary Peritoneal Cancer During PARP Inhibitor Therapy: A Multicenter Retrospective Study
MARINA ABE, TADAHIRO SHOJI, YOHEI CHIBA, ERIKO TAKATORI, YOSHITAKA KAIDO, TAKAYUKI NAGASAWA, MASAHIRO KAGABU, FUMIAKI TAKAHASHI, TAKESHI AIDA and TSUKASA BABA

Anticancer Research March 2023, 43 (3) 1265-1272; DOI: https://doi.org/10.21873/anticanres.16273
Open Access
Real-World Data on Olaparib in Relapsed BRCA-mutated Ovarian Cancer: A Multicenter GINECO RETROLA Cohort Study
HELOÏSE BOURIEN, LEÏLA BENGRINE LEFEVRE, MARIE-ANGE MOURET-REYNIER, BERNARD ASSELAIN, BRIGITTE LUCAS, CELINE GAVOILLE, CORINA CORNILA, LAURENE GAVOILLE, EMELINE COLOMBA, ANNE PATSOURIS, MICHEL FABBRO, CAMILLE CHAKIBA, PHILIPPE TOUSSAINT, HELENE SIMON, DOMINIQUE BERTON, DELPHINE GARBAY, CLAIRE GARNIER TIXIDRE, DAVID COEFFIC, AURELIE MORVAN, OLIVIER COLLARD and THIBAULT DE LA MOTTE ROUGE

Anticancer Research February 2023, 43 (2) 653-662; DOI: https://doi.org/10.21873/anticanres.16202
You have access
Evaluation of the Diagnostic Potential of Circulating MicroRNAs miR-1 and miR-21 in Patients With Ovarian Cancer
DAMIAN J. RALSER, MATEJA CONDIC, EVA EGGER, DOMINIQUE KOENSGEN, ALEXANDER MUSTEA and MATTHIAS B. STOPE

Anticancer Research December 2022, 42 (12) 5839-5845; DOI: https://doi.org/10.21873/anticanres.16092
You have access
The Activity of Vitamin C Against Ovarian Cancer Cells Is Enhanced by Hyperthermia
ALICJA BIEŃKOWSKA-TOKARCZYK, ANETA MANDA-HANDZLIK, KRZYSZTOF GAWRYCHOWSKI, URSZULA DEMKOW and MACIEJ MAŁECKI

Anticancer Research November 2022, 42 (11) 5365-5383; DOI: https://doi.org/10.21873/anticanres.16042

Main menu

User menu

Search

Ovarian cancer

Pages